`Filed: July 30, 2019
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_____________________
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________________
`AMNEAL PHARMACEUTICALS LLC,
`Petitioner
`v.
`ALKERMES PHARMA IRELAND LIMITED,
`Patent Owner
`______________________
`Case IPR2018-00943
`Patent 7,919,499
`______________________
`Joint Motion to Terminate Case No. IPR2018-00943
`
`
`
`
`
`Case IPR2018-00943
`
`I.
`
`
`Precise Relief Requested
`Pursuant to 35 U.S.C. § 317(a) and 37 C.F.R § 42.74, Petitioner Amneal
`
`Pharmaceuticals LLC and Patent Owner Patent Owner Alkermes Pharma Ireland
`
`Limited (collectively, “the Parties”) jointly request termination of the above-
`
`captioned Inter Partes Review of U.S. Patent No. 7,919,499 (“the Patent-at-
`
`Issue”), Case No. IPR2018-00943.
`
`II. Reasons for Granting the Motion
`
`Generally, the Board expects that a proceeding will terminate after the filing
`
`of a settlement agreement. See, e.g., Office Patent Trial Practice Guide, 77 Fed.
`
`Reg. 48,756, 48,768 (Aug. 14, 2012). The Board authorized the filing of the
`
`instant motion in an email communication dated July 29, 2019. Pursuant to that
`
`authorization, this Joint Motion to Terminate Case No. IPR2018-00943:
`
`(1) includes a brief explanation as to why termination is appropriate; (2) identifies
`
`all parties in any related district court litigation involving the patent in dispute and
`
`discusses the current status of each such related litigation with respect to each party
`
`of the litigation; and (3) identifies the case numbers of any pending, related inter
`
`partes review proceedings.
`
`A. Brief Explanation of Why Termination Is Appropriate
`Termination of this proceeding is appropriate because (i) oral arguments
`
`have not been presented to the Board, (ii) Petitioner will no longer be participating
`
`in this proceeding, and (iii) the Board has not yet decided the merits of the
`
`
`
`Case IPR2018-00943
`
`proceeding. The Parties have settled their disputes and executed a Settlement and
`
`License Agreement that authorizes the Parties to seek termination of this inter
`
`partes review.
`
`Pending District Court Litigations Involving the ’499 Patent
`B.
`As noted in the Parties’ Mandatory Notices, there are no related district court
`
`litigations involving the ’499 patent.
`
`C.
`
`Pending Inter Partes Review Proceedings Involving the
`’499 Patent
`As noted in the Parties’ Mandatory Notices, there are no related inter partes
`
`review proceedings involving the ’499 patent.
`
`III. Settlement Agreement
`This motion is accompanied by Exhibit 2058, a true and correct written copy
`
`of the Parties’ Settlement and License Agreement, as required by 35 U.S.C.
`
`§ 317(b) and 37 C.F.R. § 42.74(b). No other such agreements, written or oral,
`
`exist between or among the Parties.
`
`Pursuant to 35 U.S.C. § 317(b) and 37 C.F.R. § 42.74(c), and to the separate
`
`request being concurrently filed herewith, the Parties jointly request that the
`
`Settlement and License Agreement be treated as business confidential information
`
`and be kept separate from the files of the above-captioned IPR and of the
`
`’499 patent.
`
`
`
`IV. Conclusion
`For all of these reasons, the Parties respectfully request termination of this
`
`Case IPR2018-00943
`
`proceeding.
`
`
`Dated: July 30, 2019
`
`
`
`
`
`Respectfully submitted,
`
`
`
`
`
`
`By: /Tedd W. Van Buskirk/
`Tedd W. Van Buskirk (Reg. No. 46,282)
`Counsel for Petitioner
`Amneal Pharmaceuticals LLC
`
`
`
`By: /Naveen Modi/
`Naveen Modi (Reg. No. 46,224)
`Counsel for Patent Owner
`Alkermes Pharma Ireland Limited
`
`
`
`
`
`
`
`
`
`
`
`
`
`Case IPR2018-00943
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6(e), I certify that I caused to be served on the
`
`counsel for Petitioner a true and correct copy of the foregoing JOINT MOTION
`
`TO TERMINATE CASE NO. IPR2018-00943, by electronic means, on July 30,
`
`2019, at the following address of record:
`
`Michael H. Teschner
`Tedd W. Van Buskirk
`Lerner, David, Littenberg,
`Krumholz & Mentlik, LLP
`600 South Avenue West
`Westfield, NJ 07090
`
`MTeschner.ipr@ldlkm.com
`tvanbuskirk@lernerdavid.com
`litigation@lernerdavid.com
`
`Dated: July 30, 2019
`
`Respectfully submitted,
`
`By: /Naveen Modi/
`Naveen Modi
`Reg. No. 46,224
`
`Counsel for Alkermes
`
`